Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Aim. To evaluate the effectiveness of long-term (five-year) supervised physical exercise in patients with chronic heart failure (CHF) following myocardial infarction (MI) and type 2 diabetes mellitus (T2DM).Materials and Methods. The study included 88 patients with CHF of functional class II-III after MI and concomitant T2DM. In addition to standard medication therapy, patients in the main group (n = 42) performed regular moderate-intensity physical exercises for 30−60 minutes at least 5 days a week. The control group consisted of 46 patients who received standard medication therapy. Patients in both groups had similar clinical and demographic characteristics. After 5 years of follow-up, we assessed the incidence of a composite endpoint (death, MI, emergency myocardial revascularization, acute CHF decompensation), quality of life (measured by the SF36 questionnaire), levels of anxiety and depression (measured by the HADS questionnaire), and levels of fatigue (measured by the MFI-20 questionnaire). By the end of the five-year observation period, data were available for 40 patients in the main group (11 patients were excluded from the study due to discontinuation of regular physical exercise) and 42 patients in the control group.Results. The incidence of the composite endpoint was 55.2% and 80.9% in main and control group, respectively (p = 0.038). Regular physical exercise over the five-year period was associated with a higher quality of life according to the SF36 questionnaire (64.5 [63.1; 67.8] vs. 49.2 [48.4; 49.8], p = 0.001), lower levels of anxiety (5.8 [5.1; 7.7] vs. 8.0 [6.8; 9.2], p = 0.042) and depression (2.9 [2.2; 4.2] vs. 10.7 [10.5; 12.3], p = 0.001) according to the HADS questionnaire, and lower levels of general fatigue according to the MFI-20 questionnaire (9.1 [8.5; 11.2] vs. 15.1 [14.5; 15.4], p = 0.019).Conclusion. Long-term regular physical exercise in patients with CHF and T2DM improves cardiovascular outcomes and psychological status of patients.
Aim. To evaluate the effectiveness of long-term (five-year) supervised physical exercise in patients with chronic heart failure (CHF) following myocardial infarction (MI) and type 2 diabetes mellitus (T2DM).Materials and Methods. The study included 88 patients with CHF of functional class II-III after MI and concomitant T2DM. In addition to standard medication therapy, patients in the main group (n = 42) performed regular moderate-intensity physical exercises for 30−60 minutes at least 5 days a week. The control group consisted of 46 patients who received standard medication therapy. Patients in both groups had similar clinical and demographic characteristics. After 5 years of follow-up, we assessed the incidence of a composite endpoint (death, MI, emergency myocardial revascularization, acute CHF decompensation), quality of life (measured by the SF36 questionnaire), levels of anxiety and depression (measured by the HADS questionnaire), and levels of fatigue (measured by the MFI-20 questionnaire). By the end of the five-year observation period, data were available for 40 patients in the main group (11 patients were excluded from the study due to discontinuation of regular physical exercise) and 42 patients in the control group.Results. The incidence of the composite endpoint was 55.2% and 80.9% in main and control group, respectively (p = 0.038). Regular physical exercise over the five-year period was associated with a higher quality of life according to the SF36 questionnaire (64.5 [63.1; 67.8] vs. 49.2 [48.4; 49.8], p = 0.001), lower levels of anxiety (5.8 [5.1; 7.7] vs. 8.0 [6.8; 9.2], p = 0.042) and depression (2.9 [2.2; 4.2] vs. 10.7 [10.5; 12.3], p = 0.001) according to the HADS questionnaire, and lower levels of general fatigue according to the MFI-20 questionnaire (9.1 [8.5; 11.2] vs. 15.1 [14.5; 15.4], p = 0.019).Conclusion. Long-term regular physical exercise in patients with CHF and T2DM improves cardiovascular outcomes and psychological status of patients.
Patients who have suffered a myocardial infarction have a high risk of recurrent cardiovascular events – almost every fifth patient develops new episodes of acute myocardial ischemia during the first year [5]. One of the most important tasks of the therapy of these patients is the most effective and early reduction of atherogenic lipoprotein fractions to target values. The initiating basic therapy is statins, which have proven to be highly effective. However, in a number of patients, the necessary high-dose statin treatment cannot be implemented due to developing side effects or intolerance. The article discusses the issues of combined antihyperlipidemic therapy with a discussion of the role of all available groups of drugs. A possible clinical and pharmacological niche of phyto-steroid saponins is being considered.
Objective. To identify the features of transient hyperglycemia in dynamics in acute coronary heart disease in patients without impaired glycemic metabolism.Materials and methods. We performed a retrospective analysis of 178 medical records of inpatients with acute forms of coronary heart disease: transmural myocardial infarction (MI), subendocardial MI, unstable angina - initially urgently hospitalized and further treated in the institution “Gomel Regional Clinical Cardiology Center” in 2021-2022. All the patients were examined and treated in accordance with the clinical protocol for the diagnosis and treatment of diseases of the circulatory system [1]. Venous blood glucose level in dynamics was measured at hospitalization during the first hours of the disease not on an empty stomach and then on an empty stomach on the 1st, 2nd, 3rd, 4th and 5th day; according to EchoCG data on the 1st-3rd day included the ejection fraction (EF) and local contractility index (LCI). The patients were divided into groups depending on the disease, blood glucose level at hospital admission (not requiring pharmacological correction 4.1–10.9 mmol/l, requiring pharmacological correction 11 mmol/l and more [1]) and the presence/absence of a rise in blood glucose levels on the first day of hospitalization (the 1st day of the diseases).Results. Transient hyperglycemia in acute forms of coronary heart disease in patients without impaired glycemic metabolism is most evident with transmural MI, hyperglycemia of more than 11.0 mmol / l occurs in 7% of cases of all transmural MI, of which 28.5% persists on the 1st day, which requires continued pharmacological correction. Relative normalization of glucose at initial glucose values up to 11 mmol/l occurs on the 2nd day, with a tendency in transmural myocardial infarction and glucose levels over 11 mmol/l - on the 3rd day, of MI and an episode of glucose level rise in dynamics — on the 4th day of MI. Transient hyperglycemia with subendocardial MI and unstable angina is not characterized by an increase in glucose more than 11.0 mmol/l, with relative normalization on the 2nd day, while higher glucose levels are observed at admission compared to those with unstable angina.Conclusion. Transient hyperglycemia over 11 mmol/l in transmural MI in patients without glycemic metabolism disorders in 28.5% of cases remains on the 1st day of MI, which requires continued medication correction of hyperglycemia. Subendocardial MI and unstable angina are not characterized by the occurrence of transient hyperglycemia, requiring pharmacological correction, with relative normalization of the index by 2nd day.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.